Laura Ondrisova, MSc, Central European Institute of Technology, Brno, Czech Republic, discusses research exploring the role of the FoxO1-Rictor-pAkt axis in chronic lymphocytic leukemia (CLL) and how this impacts response to BCR inhibitors. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
